MHRA Responds to Countries’ Suspension of AstraZeneca Vaccine

/ General Information / By

The Medicines and Healthcare products Regulatory Agency has responded to the decision by Denmark, Norway and Iceland to suspend the Oxford Astra/Zeneca vaccine. It states: “This is a precautionary measure by the Danish, Norwegian and Icelandic authorities. It has not been confirmed that the report of a blood clot was caused by the AstraZeneca COVID-19 Vaccine. People should still go and get their COVID-19 vaccine when asked to do so.” The full statement can be read here. More information about the AstraZeneca vaccine can be seen here.